Is There a Rational Use for n-3 Fatty Acids (Fish Oils) in Clinical Medicine?
- 1 September 1991
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 42 (3) , 331-342
- https://doi.org/10.2165/00003495-199142030-00001
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Effect of Eicosapentaenoic and Docosahexaenoic Acids on Blood Pressure in HypertensionNew England Journal of Medicine, 1990
- Reduction in the Rate of Early Restenosis after Coronary Angioplasty by a Diet Supplemented with n–3 Fatty AcidsNew England Journal of Medicine, 1988
- Cardiovascular Effects of n-3 Fatty AcidsNew England Journal of Medicine, 1988
- Preliminary Report: Findings from the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1988
- Inhibition of Atherosclerosis by Cod-Liver Oil in a Hyperlipidemic Swine ModelNew England Journal of Medicine, 1986
- The triglyceride issue: A view from FraminghamAmerican Heart Journal, 1986
- Reduction of Plasma Lipids, Lipoproteins, and Apoproteins by Dietary Fish Oils in Patients with HypertriglyceridemiaNew England Journal of Medicine, 1985
- The Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart DiseaseNew England Journal of Medicine, 1985
- "SMALL IS BEAUTIFUL": α-LINOLENIC ACID AND EICOSAPENTAENOIC ACID IN MANThe Lancet, 1983
- Platelet function, thromboxane formation and blood pressure control during supplementation of the Western diet with cod liver oil.Circulation, 1983